Not yet recruitingPHASE1, PHASE2NCT06791824

Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Keymed Biosciences Co.Ltd
Principal Investigator
Jun Shi
Institute of Hematology & Blood Diseases Hospital, China
Intervention
CM313(SC) injection(biological)
Enrollment
125 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06791824 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials